| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on March 5, 2002
Accepted on March 8, 2002
From the Department of Medicine (J.H., C.D.K.), Division of Cardiology; and Department of Pharmacology and Cancer Biology (C.D.K.), Duke University Medical Center, Durham, NC.
* To whom correspondence should be addressed. E-mail: cdkontos{at}duke.edu.
AbstractPhosphatidylinositol
(PI) 3-kinase signaling regulates numerous cellular processes,
including proliferation, migration, and survival, which are required
for neointimal hyperplasia and restenosis. The
effectors of PI 3-kinase are activated by the phospholipid
products of PI 3-kinase. In this report, we investigated the
hypothesis that overexpression of the tumor suppressor protein PTEN, an
inositol phosphatase specific for the products of PI 3-kinase,
would inhibit the vascular smooth muscle cell (VSMC) responses
necessary for neointimal hyperplasia and
restenosis. Effects of PTEN were assessed in primary rabbit
VSMCs after overexpression with a recombinant adenovirus and compared
with uninfected or control virus-infected cells. PTEN was expressed
endogenously in VSMCs, and PTEN overexpression inhibited
PDGF-induced phosphorylation of
p70s6k, Akt, and glycogen synthase
kinase-3-
and -ß but not ERK1 or -2. Overexpression of PTEN
significantly inhibited both basal and PDGF-mediated VSMC proliferation
and migration, the latter possibly due in part to downregulation of
focal adhesion kinase. Moreover, PTEN overexpression induced cleavage
of caspase-3 and significantly increased apoptosis compared
with control cells. Taken together, these results demonstrate that PTEN
overexpression potently inhibits the VSMC responses required for
neointimal hyperplasia and restenosis.
Adenovirus-expressed PTEN may therefore provide a useful tool for the
local treatment of these and other vascular proliferative
disorders.
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |